English
繁體中文
简体中文
Experiencing dry, itchy eyes and blurred vision and thinking it is just because of prolonged exposure to digital screens? These symptoms could also be COVID-19 sequelae that you should be aware of. An ophthalmology team from CUHK has found that post-COVID-19 patients have a higher risk of developing dry eye disease, and that one in five people who have had COVID-19 suffer from at least one symptom related to dry eye disease……
The Microbiota I-Centre of CUHK has identified distinct gut microbiome profiles that can characterise “long COVID”. This is the world’s first study to demonstrate gut microbiota as a key determinant of long COVID. These distinct gut microbial signatures can be used as a diagnostic tool and to guide therapy……
A new pathway has been found whereby SARS-CoV-2 infects the endothelium cells – the innermost layer of the blood vessels, causing hyper inflammation, blood clotting and thrombosis in severe COVID-19 patients. In a collaborative research, a CU Medicine team has discovered that the virus induces inflammation by activating a unique cell surface receptor called (TLR) 4, without entering the host cell……
People who have recovered from a COVID-19 infection may suffer from poor memory, hair loss, difficulty in sleeping and other long-term consequences, which are commonly known as “long COVID”. CU Medicine has found that patients with long COVID have a less diverse gut microbiome, indicating that gut microbiome composition may be linked to the risk of developing long COVID, while gut microbiota modulation could facilitate timely recovery and reduce the burden of post-acute COVID-19 syndrome……
Shrimps are common and versatile ingredients that can be included in many popular dishes around the world. However, they can be a nightmare for some of us who suffer from allergic reactions to eating them, including swelling of the face, eyes and lips, and an itchy red rash. An allergic reaction to shrimp can occur at any age, therefore a reliable and accurate diagnostic method for shrimp allergy is essential to avoid severe allergic reactions……
Sinovac and BioNTech work more effectively in people who have an abundance amount of a particular bacterium called Bifidobacterium adolescentis in their gut. In most of us, this reduces with age, modern diet, stress, and the use of antibiotics, and a joint CUHK-HKU study has found that those who lack it have a lower antibody response to the vaccines. This implies that modulating the gut has potential to power up the impact of COVID vaccines……
Magnets, play an important role in daily life, sometimes an invisible one, from refrigerator doors, credit cards, computers to high-speed maglev trains and more. A CUHK Surgery team’s invention of an intelligently guided magnetic endoscope brings an exciting new advance in minimally invasive thoracic surgery. No collisions between scope and scalpel, smooth video coverage of the cavity and no clean-up interruptions……
Anticipating a newborn brings joy to parents but delays in marriages and childbirth planning make it harder to conceive successfully. Selecting a high developmental potential embryo is still the key to pregnancy even though assisted reproductive technology like conventional IVF has been advancing with time. CUHK researchers have recently developed a new predictive platform which helps doctor to select an appropriate embryo and devise transfer schemes to increase the rate of success……
A low sensitivity faecal test is used to screen for colorectal cancer. Its cause, polyps can only be detected by a probing colonoscopy. Now a CUHK Medicine team has devised a first ever, highly sensitive, non-invasive “bacterial gene markers” test on faeces. It is 94% sensitive to the cancer, and over 90% sensitive to recurring polyps - which the present test can’t detect at all……
Simeprevir was a successful drug retired from the fight against the hepatitis C virus when new drugs and advanced treatment came into the field in recent years. An international research team led by CUHK and HKU seeking an effective drug molecule against COVID-19 has re-enlisted simeprevir as a potent treatment to suppress the replication of SARS-CoV-2……